Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where er Genç is active.

Publication


Featured researches published by er Genç.


Neuroimmunomodulation | 2011

Serum Adiponectin, TNF-α, IL-12p70, and IL-13 Levels in Multiple Sclerosis and the Effects of Different Therapy Regimens

Ugur Musabak; Seref Demirkaya; Gençer Genç; Rahsan Ilikci; Zeki Odabaşı

Objectives: Multiple sclerosis (MS) is a chronic inflammatory disease of the human central nervous system. In the present study, we aimed to determine adiponectin, tumor necrosis factor-α, interleukin (IL)-12p70, and IL-13 levels in the sera of patients with MS and to investigate the effects of interferon (IFN), glatiramer acetate (GA), and immunosuppressive treatment regimens on these parameters. Methods: Fifty-seven patients with MS and 34 healthy controls were enrolled into the study. Serum cytokine levels were measured using enzyme immunoassay. Results: Significantly elevated levels of IL-12p70 and IL-13 were found in the sera of patients with MS, but decreased adiponectin levels were found in patients’ sera compared to healthy controls. The levels of IL-12p70 and IL-13 in the IFN therapy group were higher than those of the healthy controls. However, the IL-12p70 and IL-13 levels in the GA therapy group were not different from those of the healthy controls. There were no differences with regard to adiponectin levels among the subgroups of patients with MS according to therapy regimen and the healthy controls. At the end of a 2-year follow-up period, Expanded Disability Status Scale (EDSS) values were found to be increased in the IFN therapy group but unchanged in the GA therapy group. Conclusions: These findings suggest that adiponectin, IL-12p70, and IL-13 may play a role in the pathogenesis of MS. Additionally, GA therapy regimens in MS are more effective than IFN therapy with respect to decreasing the levels of IL-12p70 and IL-13 and stabilizing the EDSS value.


Journal of Stroke & Cerebrovascular Diseases | 2013

Clinical Properties of Regional Thalamic Hemorrhages

Serhat Tokgoz; Seref Demirkaya; Semai Bek; Tayfun Kasikci; Zeki Odabasi; Gençer Genç; Mehmet Yücel

BACKGROUND Thalamic hemorrhage constitutes 6% to 25% of intracerebral hemorrhages. Vascular lesions affecting the thalamus may cause a variety of clinical symptoms. This retrospective study aims to evaluate localization of hemorrhage and clinical symptoms in patients with thalamic hemorrhage. METHODS One hundred and one patients with thalamic hemorrhage were examined retrospectively in our department. Hemorrhages were classified into 5 groups according to computed tomography: medial (thalamoperforate), anterolateral (tuberothalamic), posterolateral (thalamogeniculate), dorsal (posterior choroidal), and global. The relation between volume, localization, and penetration to adjacent structures/ventricles of hemorrhage and risk factors, clinical features, and prognosis were evaluated. RESULTS The study group included 101 patients. Eighty-two percent of the patients had hypertension, 19.8% had diabetes mellitus, 14.9% had cardiac disease, and 5.9% had chronic renal failure. Mean blood pressure was 173/101 mm Hg. Decreased Glasgow coma scale was significantly higher in the global hemorrhage group than in all regional groups (Chi-square, 10.54; P = .002). Medial group hemorrhages had a significantly higher rate than anterolateral, posterolateral, and dorsal intraventricular expansion. Out of speech disorders, 49% of patients had a right thalamic lesion (especially dysarthria) and 51% of patients had a left thalamic lesion (mostly aphasia). CONCLUSIONS In the study, we detected that the most important risk factor in thalamic hemorrhage is hypertension. The prognosis is worse in global and medial group hemorrhages, especially those which rupture to the ventricle, than the other groups. Thalamic lesions cause a variety of symptoms, including forms of aphasia, such as crossed dextral aphasia.


Multiple Sclerosis International | 2012

Strength-Duration Time Constant in Peripheral Nerve: No Abnormality in Multiple Sclerosis

Gençer Genç; Semai Bek; Tayfun Kasikci; Ümit Hıdır Ulaş; Seref Demirkaya; Zeki Odabasi

Objectives. To investigate the properties of the strength-duration time constant (SDTC) in multiple sclerosis (MS) patients. Methods. The SDTC and rheobase in 16 MS patients and 19 healthy controls were obtained following stimulation of the right median nerve at the wrist. Results. SDTC and rheobase values were 408.3 ± 60.0 μs and 4.0 ± 1.8 mA in MS patients, versus 408.0 ± 62.4 μs and 3.8 ± 2.1 mA in controls. The differences were not significant in SDTC or rheobase values between the patients and controls (P = 0.988 for SDTC and P = 0.722 for rheobase). Conclusion. Our study showed no abnormality in relapsing remitting MS patients in terms of SDTC, which gives some indirect information about peripheral Na+ channel function. This may indicate that alterations in the Na+ channel pattern in central nervous system (CNS) couldnot be shown in the peripheral nervous system (PNS) in the MS patients by SDTC. The opinion that MS can be a kind of channelopathy might be proven by performing other axonal excitability tests or SDTC in progressive forms of MS.


Neuro-Ophthalmology | 2009

Gabapentin and Superior Oblique Myokymia

Semai Bek; Tayfun Kasikci; Gençer Genç; Zeki Odabasi

Superior oblique myokymia (SOM) is an uncommon disorder characterized by episodic monocular oscillopsia. Though the mechanism of SOM is not fully established, recent reports focus on the role of vascular compression. Several medications have been reported to be of benefit but a standard protocol for SOM has not been established. This case report documents a complete symptom relief in SOM with a documented vascular compression using gabapentin.


Journal of Neurology | 2010

Cerebral vasomotor reactivity in epilepsy patients

Semai Bek; Tayfun Kasikci; Güray Koç; Gençer Genç; Şeref Demirkaya; Zeki Gökçil; Zeki Odabasi


Journal of Neurology | 2010

Lateralization of cerebral blood flow in juvenile absence seizures.

Semai Bek; Tayfun Kasikci; Gençer Genç; Şeref Demirkaya; Zeki Gökçil; Zeki Odabasi


Journal of Neurology | 2010

Vasomotor properties of the M2 segment of the middle cerebral artery

Semai Bek; Tayfun Kasikci; Gençer Genç; Şeref Demirkaya; Zeki Odabasi


Clinical Neurophysiology | 2008

THO08 Evoked potentials follow up in subacute combined degeneration

Gençer Genç; Semai Bek; Özgür Arslan; Erdal Eroglu; Ümit Hıdır Ulaş; Zeki Odabasi


Noro Psikiyatri Arsivi | 2017

Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis

Gençer Genç; Seref Demirkaya; Semai Bek; Zeki Odabasi


Archive | 2016

Clinical, Radiological and Electrophysiological Comparison of Immunomodulatory Therapies in Multiple Sclerosis Multipl Sklerozda İmmunmodulatuvar Tedavilerin Klinik, Radyolojik ve Elektrofizyolojik Olarak Karşilaştirilmasi

Gençer Genç; Semai Bek

Collaboration


Dive into the er Genç's collaboration.

Top Co-Authors

Avatar

Semai Bek

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Zeki Odabasi

University of Alabama at Birmingham

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erdal Eroglu

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Zeki Gökçil

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Mehmet Yücel

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Ugur Musabak

Military Medical Academy

View shared research outputs
Top Co-Authors

Avatar

Zeki Odabaşı

Military Medical Academy

View shared research outputs
Researchain Logo
Decentralizing Knowledge